Detalhe da pesquisa
1.
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells.
Cell
; 186(21): 4567-4582.e20, 2023 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37794590
2.
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.
Br J Haematol
; 204(4): 1429-1438, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38348544
3.
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
Blood
; 139(9): 1289-1301, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34521108
4.
Progressive multifocal leukoencephalopathy in multiple myeloma.
Eur J Haematol
; 110(3): 322-329, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36465014
5.
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Am J Hematol
; 98(1): 140-147, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35567778
6.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37334852
7.
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; : 10781552231189199, 2023 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37603585
8.
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
Br J Haematol
; 197(3): 326-338, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35286719
9.
Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma.
N Engl J Med
; 390(4): 368-369, 2024 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38265649
10.
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood
; 136(26): 3033-3040, 2020 12 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33367546
11.
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
J Oncol Pharm Pract
; 28(4): 892-897, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35191732
12.
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking.
Clin Chem
; 68(1): 230-239, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34383886
13.
Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients.
Support Care Cancer
; 29(2): 997-1003, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32556621
14.
Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Biol Blood Marrow Transplant
; 26(1): e7-e15, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31526843
15.
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
Cancer
; 126(9): 1837-1855, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32073653
16.
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Transfusion
; 60(8): 1867-1872, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32654201
17.
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Am J Hematol
; 95(7): 792-798, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32242967
18.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30256954
19.
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Biol Blood Marrow Transplant
; 25(5): 1004-1010, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30481595
20.
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 25(3): 515-521, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30315941